What is PBD Biotech?
PBD Biotech is at the forefront of developing novel phage-based diagnostic technology specifically for veterinary applications. Their proprietary platform is engineered to detect critical mycobacteria, including Mycobacterium Bovis (responsible for bovine tuberculosis) and Mycobacterium avium subsp. paratuberculosis (MAP), which causes Johne's disease. These pathogens represent substantial threats to animal health and productivity within the agricultural sector, making PBD Biotech's diagnostic solutions vital for disease management and economic stability in farming.
How much funding has PBD Biotech raised?
PBD Biotech has raised a total of $3.2M across 1 funding round:
Unspecified
$3.2M
Unspecified (2021): $3.2M with participation from Mercia Group and Foresight Group
Key Investors in PBD Biotech
Mercia Group
Mercia Group Ltd is an entity focused on providing specialized training and support services, particularly for accounting professionals, covering regulatory updates and skill development. Their involvement suggests a strategic interest in companies that may require robust business support or operate within regulated sectors.
Foresight Group
Foresight Group is a prominent independent investment manager with a focus on infrastructure and private equity. Their participation indicates a strategic investment aimed at fostering growth and development in PBD Biotech's innovative diagnostic technology within the agricultural and veterinary markets.
What's next for PBD Biotech?
The substantial enterprise-level funding and recent strategic investment position PBD Biotech for accelerated expansion and technological advancement. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden market penetration for their advanced diagnostic tools. The company's focus on combating significant agricultural diseases suggests a trajectory aimed at becoming a leader in global veterinary health, potentially leading to further strategic partnerships or funding rounds as they scale their operations and impact.
See full PBD Biotech company page
